2. Academic Validation
  3. WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy

WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy

  • Free Radic Biol Med. 2017 Jul;108:280-299. doi: 10.1016/j.freeradbiomed.2017.03.012.
Jiao Wan 1,  Xiaoyan Hou 1,  Zhanmei Zhou 1,  Jian Geng 2,  Jianwei Tian 1,  Xiaoyan Bai 3,  Jing Nie 4
Affiliations

Affiliations

  • 1 Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangzhou, Guangdong, PR China.
  • 2 Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, PR China.
  • 3 Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangzhou, Guangdong, PR China. Electronic address: xiaoyanbai@smu.edu.cn.
  • 4 Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Guangzhou, Guangdong, PR China. Electronic address: niejing@smu.edu.cn.
PMID: 28315733 DOI: 10.1016/j.freeradbiomed.2017.03.012
Abstract

Epigenetic modulation of podocyte injury plays a pivotal role in diabetic nephropathy (DN). Wilm's tumor 1 (WT1) has been found to have opposing roles with β-catenin in podocyte biology. Herein, we asked whether the Histone Methyltransferase enzyme enhancer of zeste homolog 2 (EZH2) promotes WT1-induced podocyte injury via β-catenin activation and the underlying mechanisms. We found that WT1 antagonized EZH2 and ameliorated β-catenin-mediated podocyte injury as demonstrated by attenuated podocyte mesenchymal transition, maintenance of podocyte architectural integrity, decreased podocyte Apoptosis and oxidative stress. Further, we provided mechanistical evidence that EZH2 was required in WT1-mediated β-catenin inactivation via repression of secreted frizzled-related protein 1 (sFRP-1), a Wnt antagonist. Moreover, EZH2-mediated silencing of sFRP-1 was due to increased histone 3 lysine 27 trimethylation (H3K27me3) on its promoter region. WT1 favored renal function and decreased podocyte injury in diabetic rats and DN patients. Notably, WT1 exhibited clinical and biological relevance as it was linked to dropped serum creatinine, decreased proteinuria and elevated estimated glomerular filtration rate (EGFR). We propose an epigenetic process via the WT1/EZH2/β-catenin axis in attenuating podocyte injury in DN. Targeting WT1 and EZH2 could be potential therapeutic approaches for DN.

Keywords

Diabetic nephropathy; EZH2; Podocyte injury; WT1; β-catenin.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z